Kalos Management’s MiMedx Group MDXG Stock Holding History

Kalos Management’s Portfolio MDXG Stock Details MDXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-575	Closed	-$1.96K	–	268
2023 Q1	$1.96K	Buy	+575	New	+$2.23K	﹤0.01%	342

Other funds holding MDXG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Richmond Brothers Jackson, Michigan $150M AUM 14.02% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Kalos Management's MDXG Position: Q2 2023 in Review

Kalos Management sold out of MiMedx Group (MDXG) in Q2 2023, closing a stake of 575 shares — an estimated $1.96K sold.

Kalos Management first reported a position in MDXG in Q1 2023 and held it in 1 quarter. The position peaked at $1.96K in Q1 2023. 177 funds tracked by Wall St. Rank hold MDXG as of Q2 2023.

Kalos Management reported no remaining MiMedx Group position as of Q2 2023 after selling out during the quarter.
Kalos Management sold 575 MiMedx Group shares in Q2 2023, an estimated $1.96K.
Kalos Management first reported a position in MiMedx Group in Q1 2023 and held it in 1 quarter.
Kalos Management's MiMedx Group position peaked at $1.96K in Q1 2023.
177 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2023.

Based on Kalos Management's 13F filing for Q2 2023, filed 9 Aug 2023.